Cases 1 - 3 of 3
In Re: Aflibercept Patent Litigation
as 1:2024md03103
Not Yet Classified:
AFLIBERCEPT PATENT LITIGATION
Plaintiff:
Regeneron Pharmaceuticals, Inc.
Defendant:
Mylan Pharmaceuticals, Inc., AMGEN USA, INC., BIOCON BIOLOGICS INC. and others
Cause Of Action: 28 U.S.C. ยง 1338 Patent Infringement
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 24-1402
Plaintiff:
REGENERON PHARMACEUTICALS, INC.
Defendant:
MYLAN PHARMACEUTICALS INC., BIOCON BIOLOGICS INC. and AMGEN USA, INC.
Regeneron Pharmaceuticals, Inc. v. Mylan Pharmaceuticals Inc.
as 24-1405
Plaintiff:
REGENERON PHARMACEUTICALS, INC.
Defendant:
MYLAN PHARMACEUTICALS INC., BIOCON BIOLOGICS INC. and AMGEN USA, INC.
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
